Additional Metadata
Persistent URL dx.doi.org/10.1016/j.ejca.2020.07.014, hdl.handle.net/1765/129777
Journal European Journal of Cancer
Citation
Diekstra, F.P, Malmberg, R. (Ruben), Sleijfer, S, & van Leeuwen, R.W.F. (2020). Letter to the editor: Comments on ‘A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation’. European Journal of Cancer, 138, 54–56. doi:10.1016/j.ejca.2020.07.014